RT @GUMDROPtrials@twitter.com

Open now: Phase I/II study of M9241 in combination with Docetaxel in adults with #metastatic #CastrationSensitive and #CastrationResistant #ProstateCancer @Dr_RaviMadan@twitter.com @NIH@twitter.com @NCIResearchCtr@twitter.com
https://www.gumdroptrials.org/prostate-cancer-trials/

🐦🔗: https://twitter.com/GUMDROPtrials/status/1600898002855542784